Invokana (canagliflozin) Tablets

Invokana is a prescription oral tablet that contains canagliflozin for adults with type 2 diabetes. This page reviews key clinical and practical details that often come up when checking invokana price, including dosing basics, safety points, and storage. Ships from Canada to US access may be an option through a prescription referral process, including for some people paying cash without insurance.

Content here is intended to support careful reading of the official label and clinician instructions. It summarizes how this medicine lowers blood glucose, who it is commonly prescribed for, and what monitoring is typically discussed. Sections below also cover interactions, travel handling, and how to compare similar therapies. Any decisions about starting, stopping, or changing therapy should be made with a licensed healthcare professional.

Because kidney function and other conditions affect whether this medicine is appropriate, the same product may be used differently across patients. Keeping a current medication list and recent lab results available can help clinical visits go more smoothly. For convenience, related guides and browseable hubs are linked throughout this page.

What Invokana Is and How It Works (invokana price)

Invokana is the brand name for canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor (kidney glucose transporter blocker). In adults with type 2 diabetes, SGLT2 inhibitors reduce reabsorption of glucose in the kidneys, which increases glucose excretion into the urine. This mechanism is different from insulin and from medicines that increase insulin secretion. For related options in the same class, see the SGLT2 Inhibitors hub.

CanadianInsulin operates as a prescription referral platform.

Because more glucose is passed into urine, the medicine can also increase urination and fluid losses in some people. That shift helps explain several practical counseling points, such as attention to hydration and awareness of genital mycotic infection (yeast infection). For a deeper class overview, the guide Invokana Drug Class covers how SGLT2 inhibitors fit into blood sugar management. If an order is eligible, US delivery from Canada may be coordinated through a licensed dispensing pharmacy after required documentation is confirmed.

Who It’s For

This medicine is generally prescribed for adults with type 2 diabetes as an add-on to lifestyle measures and, when needed, other glucose-lowering therapies. Depending on a patient’s history, a clinician may also consider it for people with type 2 diabetes who have certain cardiovascular or kidney risk factors, consistent with labeling. The browseable hub Type 2 Diabetes summarizes common medication categories used in this condition.

Invokana is not indicated for type 1 diabetes and is not used to treat diabetic ketoacidosis. It may be unsuitable in some people with significant kidney impairment, and it may require additional caution in older adults or those prone to dehydration. A prescriber will usually review kidney status using eGFR (estimated glomerular filtration rate, a kidney function estimate) before starting and during therapy. Background information on kidney disease considerations is available under Chronic Kidney Disease.

Contraindications and key warnings include hypersensitivity to canagliflozin and situations where risks outweigh benefits, such as recurring severe genital infections or frequent volume depletion. Foot problems, peripheral vascular disease, or neuropathy may require extra attention because SGLT2 inhibitors have been associated with lower-limb complications in some patients. When patients are weighing multiple therapies, invokana price is only one factor; clinical eligibility and safety monitoring often matter more.

Dosage and Usage

Invokana is taken by mouth once daily, typically before the first meal of the day, following the prescriber’s instructions. Tablets should be swallowed whole with water. If a dose is missed, the official label generally advises taking it when remembered unless it is close to the next dose; double-dosing is not recommended. For label-level dosing details, see Invokana Dosage.

Dose selection and whether a higher strength is appropriate depend on kidney function, other medicines, and treatment goals. Clinicians often reassess kidney labs after starting because SGLT2 inhibitors change urinary glucose and fluid handling. During acute illness, prolonged fasting, or around planned procedures, a clinician may advise temporary interruption to reduce the risk of ketoacidosis. For general context on how long canagliflozin remains in the body, Invokana Half Life explains the concept without replacing label instructions.

• Timing: often before first meal.
• Hydration: monitor for excess urination.
• Monitoring: periodic kidney labs.
• Missed dose: follow label guidance.

In practice, changes in kidney function can affect invokana price indirectly by changing the strength or suitability of therapy over time, so clinicians typically reassess labs rather than relying on a fixed plan indefinitely.

Strengths and Forms

Invokana is supplied as oral tablets in two strengths. Availability can vary by pharmacy and jurisdiction, and packaging may differ by manufacturer lot. A prescriber selects a strength based on kidney function, other therapies, and the intended role in the patient’s regimen. When reviewing medication lists, it can help to record both the brand name and the generic name (canagliflozin) to reduce confusion with combination products.

When comparing strengths, invokana price may differ between the 100 mg and 300 mg presentations, and supply size can also change out-of-pocket totals. Generic availability for canagliflozin may vary by country and over time, so clinicians and pharmacists may confirm current options during medication reconciliation.

Storage and Travel Basics

Invokana tablets are typically stored at controlled room temperature in a dry location, away from excessive heat and moisture. Keep the medicine in its original container with the pharmacy label, and store it out of reach of children and pets. Do not use tablets that appear damaged, discolored, or past the expiration date. If a pill organizer is used, confirm that the tablets remain protected from humidity.

For travel, keep tablets in carry-on luggage to avoid temperature extremes, and bring an up-to-date medication list in case medical care is needed away from home. Many people also pack a few extra days of medicine to cover unexpected travel changes. If vomiting, severe diarrhea, or reduced fluid intake occurs while traveling, clinicians often reassess SGLT2 inhibitor use because dehydration can worsen kidney stress.

Quick tip: Keep a photo of the prescription label for reference.

Side Effects and Safety

Common side effects reported with canagliflozin include increased urination, thirst, and genital yeast infections, along with urinary tract infections in some patients. Dizziness or lightheadedness can occur, especially when starting therapy or when combined with diuretics. Because the mechanism increases urinary glucose, careful hygiene and early recognition of irritation or discharge can be relevant practical considerations. The guide Minimize Invokana Side Effects outlines commonly discussed mitigation strategies that do not replace clinician instructions.

Serious risks can include diabetic ketoacidosis (a dangerous acid buildup), severe urinary infections, acute kidney injury, low blood pressure from volume depletion, and rare necrotizing infections of the perineum (Fournier’s gangrene). Some patients may have increased risk of hypoglycemia when Invokana is used with insulin or insulin secretagogues, even though Invokana alone does not usually cause low blood sugar. Lower-limb complications (including amputation risk) and fracture risk are also noted in warnings and precautions for this medicine.

• Seek urgent care: severe nausea or vomiting.
• Seek urgent care: rapid breathing or confusion.
• Seek urgent care: severe genital pain or swelling.
• Seek urgent care: fainting or severe dizziness.

Licensed Canadian pharmacies dispense medications.

Why it matters: Some serious reactions can progress quickly and require same-day assessment.

For budgeting discussions, invokana price should not be separated from expected monitoring needs, such as kidney labs and review of infection symptoms, because follow-up can influence the overall care plan.

Drug Interactions and Cautions

Drug interactions with canagliflozin are often related to additive effects on blood pressure, fluid status, or blood sugar. Diuretics can increase the likelihood of volume depletion, and blood pressure medicines may compound dizziness in susceptible patients. When used with insulin or sulfonylureas, clinicians may reassess the overall regimen to reduce hypoglycemia risk. It is important that all prescribers involved have an updated list of prescription, over-the-counter, and herbal products.

Other interactions may involve medicines that affect canagliflozin metabolism (for example, certain enzyme-inducing anticonvulsants or antibiotics), which can change drug exposure. Canagliflozin can also affect digoxin concentrations in some cases, so clinicians may monitor levels or clinical response when these drugs are combined. Additional cautions often include alcohol use disorder, very low-carbohydrate diets, or recurrent dehydration, because these can increase ketoacidosis risk. For planned surgery, clinicians may advise holding SGLT2 inhibitors in advance based on label and institutional protocols.

• Diuretics: higher dehydration risk.
• Insulin: hypoglycemia monitoring.
• Digoxin: potential level changes.
• UGT inducers: reduced exposure possible.

Compare With Alternatives

Invokana is one option within the SGLT2 inhibitor class. Other medicines in this class include empagliflozin and dapagliflozin, which share the same general kidney-based mechanism but have different labeling details, renal thresholds, and evidence bases for specific outcomes. For product comparisons, see Jardiance Tablets and Farxiga Dapagliflozin. A longer discussion of common comparison points is available in Jardiance Vs Invokana.

Outside of SGLT2 inhibitors, clinicians may compare options such as metformin, DPP-4 inhibitors, GLP-1 receptor agonists, or insulin depending on A1C goals, kidney function, weight considerations, and tolerability. Combination tablets may also be considered for regimen simplification, such as canagliflozin/metformin products (including extended-release formulations like Invokamet XR) when appropriate. The best alternative depends on clinical factors, contraindications, and how well a patient can adhere to the regimen.

• Same class: other SGLT2 inhibitors.
• Different class: metformin-based therapy.
• Add-on options: DPP-4 or GLP-1.
• Combination tablets: fewer pills daily.

Pricing and Access

Out-of-pocket totals for prescription medicines vary widely by jurisdiction, pharmacy contracting, and strength, and invokana price is commonly influenced by tablet strength and days supplied. Insurance formularies may place SGLT2 inhibitors on different tiers, and coverage rules can change year to year. People comparing retail options may also see differences between cash-pay and benefit pricing depending on plan design.

Some individuals paying without insurance prefer a cash-pay pathway when coverage is limited or unavailable, but eligibility still depends on a valid prescription and clinical appropriateness. For background on current generic status and what that can mean for availability, see Invokana Generic Guide. Available site-wide programs are listed on Available Promotions.

Prescription details may be verified with the prescriber when required.

• Strength: 100 mg vs 300 mg.
• Quantity: 30 vs 90 days.
• Coverage: formulary tier rules.
• Combinations: added medicines used.

CanadianInsulin supports cross-border access by coordinating prescription review and fulfillment through Canadian dispensing partners, with medication supplied by licensed pharmacies once requirements are met. Pricing discussions should be separated from clinical decisions, and patients should confirm dosing and monitoring plans with their prescriber.

Authoritative Sources

For the most complete safety information, dosing limits, and contraindications, consult the official prescribing information. Neutral label access is available from the FDA here: FDA Drug Labels Database.

For patient-friendly medication information and safety warnings, a reputable overview is available here: MedlinePlus Canagliflozin Information.

For site processing, submit the required prescription documentation; eligible shipments may use prompt, express, cold-chain shipping when required.

This content is for informational purposes only and is not a substitute for professional medical advice.